Orthopedic imaging technology developer EOS Imaging reported 63% growth in revenues in the first half of the company's financial year as system shipments resumed after being interrupted by the COVID-19 outbreak.
For the first half, EOS posted sales of 9.8 million euros ($11.4 million U.S.), up 63% compared with 6 million euros ($7 million) in the first half of 2019. The company cut its net loss roughly in half, to 4.9 million euros ($5.7 million) in the most recent period, compared with 10 million euros ($11.7 million) in the first half of 2019.
The company said it has seen a resumption of equipment purchasing following the COVID-19 outbreak, as well as the first installations of its new EOSedge orthopedic digital radiography system in the U.S. and Europe. Additionally, the company saw a 17% decline in operational expenses, the result of lower marketing expenses due to trade shows and other events canceled due to the pandemic.
